METHAPHARM, INC.
BOCA RATON, FLORIDA

Methapharm, Inc., founded on May 2, 2000, is a privately held specialty pharmaceutical company headquartered in Boca Raton, Florida. The company focuses on the acquisition, licensing, and promotion of healthcare products predominantly within North America, while also maintaining an international presence through a European affiliate coordinating global licensing opportunities. Methapharm markets its own proprietary healthcare products and collaborates with partner companies to offer a comprehensive line of specialty pharmaceuticals. As an Authorized Distributor of Record (ADR) for Methapharm Inc., this entity plays a crucial role in the distribution network, ensuring product availability across diverse regions. The company's commitment is evident through its multi-state operations extending from the U.S. and Canada to broader international markets. Led by key figures like Christopher Calenti (Secretary/Treasurer) and Craig Baxter (President/ Director), Methapharm fosters strategic decision-making that aligns with industry standards and regulatory compliance. Its robust contact infrastructure, including a national telephone presence, provides accessible medical information services and avenues for reporting adverse events to ensure consumer safety. Methapharm is registered as a Florida company under the For-Profit Corporation (FORP) classification with a Florida business status model. The firm's last annual report was submitted on December 5, 2024, maintaining transparency in its operations and corporate governance. Further information about Methapharm can be accessed through their website at methapharm.com or by reaching out directly to their mailing address located in Boca Raton, FL.